44 research outputs found

    Bionic Structure Inspired by Tree Frogs to Enhance Damping Performance

    No full text
    Magnetic fluid shock absorbers (MFSAs) have been successfully utilized to eliminate microvibrations of flexible spacecraft structures. The method of enhancing the damping efficiency of MFSAs has always been a critical issue. To address this, we drew inspiration from the tree frog’s toe pads, which exhibit strong friction due to their unique surface structure. Using 3D printing, we integrated bionic textures copied from tree frog’s toe pad surfaces onto MFSAs, which is the first time to combine bionic design and MFSAs. Additionally, this is also the first time that surface textures have been applied to MFSAs. However, we also had to consider practical engineering applications and manufacturing convenience, so we modified the shape of bionic textures. To do so, we used an edge extraction algorithm for image processing and obtained recognition results. After thorough consideration, we chose hexagon as the shape of surface textures instead of bionic textures. For theoretical analysis, a magnetic field–flow field coupling dynamic model for MFSAs was built for the first time to simulate the magnetic fluid (MF) flow in one oscillation cycle. Using this model, the flow rate contours of the MF were obtained. It was observed that textures cause vortexes to form in the MF layer, which produced an additional velocity field. This increased the shear rate, ultimately leading to an increase in flow resistance. Finally, we conducted vibration reduction experiments and estimated damping characteristics of the proposed MFSAs to prove the effectiveness of both bionic texture and hexagon surface textures. Fortunately, we concluded that hexagon surface textures not only improve the damping efficiency of MFSAs but also require less MF mass

    Chemical ingredients fingerprint.

    No full text
    <p>Note: G1 Alkaloids; G2 Amino acid; G3 Fatty acid; G4 Flavonoids and its glycosides; G5 Glycosides; G6 Phenylpropanoids and its derivates; G7 Protein and Enzyme; G8 Quinones; G9 Saccharides and its derivates; G10 Steroids and its glycosides; G11 Stilbenoids; G12 Terpenoids and its derivates; G13 Triterpenoids and its glycosides; G14 Volatile oils.</p

    Chemical ingredients network.

    No full text
    <p>Note: Node represents chemical ingredient, while node size corresponds to the weighted degree centrality of a chemical ingredient. Each node is colored according to community membership, which was determined using a modularity optimization method. The strength of the lines corresponds to the frequency of the combination into sampled formulae between two chemical ingredients. Vertex positions determined using spectral graph analytic methods according to the normalized Laplacian so that chemical ingredients that are strongly interconnected positioned nearer to each other. Boxes illustrate outstanding nodes and show dominant structural types of chemical ingredients characterizing communities. The numbers in the parentheses in the boxes indicate how many percentages of chemical ingredients are contained by representative herbs of specific communities. Representative herbs are top one or two Chinese medicines which contain more than 50% chemical ingredients in specific communities. Square brackets specify chemical ingredients at the distant positions by showing their chemical names, chemical structural types, and corresponding herbs.</p

    Additional file 1 of The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study

    No full text
    Additional file 1: Supplemental Fig. 1. Flow chart of patient inclusion/exclusion. GnRH-a, gonadotropin-releasing hormone agonist; n, number of participants; COH, controlled ovary hyperstimulation; COVID-19, coronavirus; ET, embryo transfer; PGT, preimplantation genetic diagnosis/screening; OHSS, ovarian hyperstimulation syndrome; FSH, follicle-stimulating hormone; AMH, anti-Müllerian hormone; AFC, antral follicle count; BMI, body mass index

    Ingredient ranking by different centralities.

    No full text
    <p>Note: The NA represents chemical ingredient whose number of CAS is unavailable in SCIfinder.</p
    corecore